Acasti Pharma Forecast and Stock Analysis
Technical ACST stock analysis for Wednesday May 22, 2019.
|Price to book||USD 2.96|
|Next Earnings Date||2019-05-22|
Acasti Pharma gained 0.58% in the last trading day ( Wednesday, 22nd May 2019 ), rising from $0.89 to $0.90 , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During day the stock fluctuated 5.81% from a day low at $0.86 to a day high of $0.91. The price has risen in 7 of the last 10 days and is up by 12.37% over the past 2 weeks. Volume fell in the last day by -84 420 shares, and in total, 97 646 shares bought and sold for approximately $87 891.20. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
- 30 day high of the ACST stock price was $0.96 and low was $0.76.
- 90 day high was $1.12 and low was $0.76.
- 52 week high for the Acasti Pharma - $1.80 and low - $0.43.
Acasti Pharma has broken the wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction there will be support on the roof on the current trend broken, which is $0.86, a level that may pose a second chance to hit a runner. According to fan-theory $0.97 will be the next possible trendtop level and thereby pose a resistance level which may not be broken on the first attempt.
Acasti Pharma holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $0.86 and $0.89. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday May 13, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
RSI14 is 64 and the stock is currently not being overbought or oversold
Support & Resistance
Acasti Pharma finds support from accumulated volume at $0.90.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.05 between high and low, or 5.81%. For the last week the stock has had a daily average volatility of 5.44%.
Our recommended stoploss: $0.87 (-3.73%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 7 days ago.)
5.44 %Average volatility
Very Low Low Medium High Very High
Acasti Pharma holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us